Skip to main content

Table 8 Summary of DC vaccination and clinical responses

From: A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

Patient

DC injections

Regular (boosting)

Best response (duration)

1

4

PDa

2

2

PD

3

4

PD

4

4

PD

5

4(2)

SDb (105 days)

6

4

PD

7

4

PD

8

3

PD

9

4

PD

10

4

PD

11

4

PD

12

4(1)

SD (98 days)

  1. aPD: progressive disease
  2. bSD: stable disease